EDGAR Filing Documents for 0000898432-06-000300

Form SC 13G - Statement of Beneficial Ownership by Certain Investors:

SEC Accession No. 0000898432-06-000300

Filing Date

2006-03-13

Accepted

2006-03-10 18:50:48

Documents

Group Members

BIOTECHNOLOGY VALUE FUND II, L.P.BVF INC.BVF INVESTMENTS, L.L.C.BVF PARTNERS L.P.INVESTMENT 10, L.L.C.

Document Format Files

Seq	Description	Document	Type	Size
1	ADVANCED LIFE SCIENCES	bvf-neuro_sc13g.htm	SC 13G	102736
2		exhibit_99.htm	EX-99	12914
	Complete submission text file	0000898432-06-000300.txt		117741

Mailing Address 227 W MONROE STREET, SUITE 4800 227 W MONROE STREET, SUITE 4800 CHICAGO IL 60606

Business Address 227 W MONROE STREET, SUITE 4800 227 W MONROE STREET, SUITE 4800 CHICAGO IL 60606 415-288-23

BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

IRS No.: 363924731 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G
SIC: 6282 Investment Advice

Mailing Address 1440 DAVEY ROAD WOODRIDGE IL 60517

Business Address (630) 739-6744

Advanced Life Sciences Holdings, Inc. (Subject) CIK: 0001322734 (see all company filings)

IRS No.: 300296543
Type: SC 13G | Act: 34 | File No.: 005-81504 | Film No.: 06680607
SIC: 2836 Biological Products, (No Diagnostic Substances)